Cough Archives - PharmaLive

Merck Remains Committed to Chronic Cough Drug Following FDA Rejection

Clinical Trials, Complete Response Letter, Cough, FDA/Regulatory, Japan, Merck, New Drug Applications, P2X3 receptor antagonists, R&D, Refractory Chronic Cough, United States

The U.S. Food and Drug Administration issued a Complete Response Letter to Merck & Co. for the company’s New Drug Application for gefapixant for refractory chronic cough or unexplained chronic cough.

January 24, 2022/by Reuters Health

AI Can Detect Covid-19 by Analyzing Coughs and More Related Research

ACE2 (angiotensin-converting enzyme-2), Antibodies, Artificial Intelligence, Blood Samples, Brigham and Women's Hospital, Cells, Children, Coronavirus Disease 2019 (COVID-19), Cough, Massachusetts Institute of Technology (MIT), Mouth, R&D, Researchers, RNA, Science Translational Medicine

Researchers at Massachusetts Institute of Technology (MIT) developed an artificial intelligence (AI) model able to detect asymptomatic Covid-19 cases by identifying differences in the sounds of coughs between healthy and infected people.

November 4, 2020/by Andrew Humphreys

Halloween Horror: Is it Covid-19 or Another Infection of the Night?

Coronavirus, Coronavirus Disease 2019 (COVID-19), Cough, COVID-19 Infections, Dyspnea (shortness of breath), Fever, Halloween, Healthcare Professionals, Holidays, Outbreaks, Surveys

The wind howls and new-fallen leaves swirl around. There’s a sense of dread hanging in the air. Monsters are about, spreading terror across the land. The sound of coughing and gasping breath is coming up fast. A slow look over your shoulder reveals the sweaty, nightmare visage of Covid-19 – or does it?

October 31, 2020/by Andrew Humphreys

U.S. CDC says coronavirus could spread through air

Airborne Germs, Airborne Viruses, Cough, Covid-19 Airborne Transmission, Social Distancing, Studies, U.S. Centers for Disease Control and Prevention, World Health Organization

The U.S. Centers for Disease Control and Prevention warned that Covid-19 could spread through airborne particles that can remain suspended in the air and travel beyond six feet.

September 21, 2020/by Andrew Humphreys

Vernalis: FDA Issues CRL on CCP-07 NDA

Colds, Complete Response Letter, Cough, FDA, FDA/Regulatory

Vernalis plc announces today that the US Food and Drug Administration issued a Complete Response Letter (CRL) regarding the New Drug Application for CCP-07.

April 21, 2017/by Marketwired